Tatsushi Toda Selected Research

COVID-19

10/2021	Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database.
9/2021	The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database.
5/2020	Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsushi Toda Research Topics

Disease

40	Muscular Dystrophies (Muscular Dystrophy) 08/2022 - 03/2002
30	Parkinson Disease (Parkinson's Disease) 12/2023 - 01/2002
27	Walker-Warburg Syndrome 01/2023 - 03/2002
20	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 06/2003
12	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2005
9	Huntington Disease (Huntington's Disease) 01/2020 - 06/2003
8	Muscular Diseases (Myopathy) 10/2023 - 01/2012
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2022 - 03/2013
6	Stroke (Strokes) 12/2023 - 01/2013
6	Myositis (Idiopathic Inflammatory Myopathies) 12/2022 - 05/2013
6	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020 - 04/2007
5	Epilepsy (Aura) 04/2024 - 03/2013
5	Dementia (Dementias) 12/2023 - 08/2006
4	Inflammation (Inflammations) 04/2024 - 11/2019
4	Autoimmune Diseases (Autoimmune Disease) 02/2024 - 01/2013
4	Multiple System Atrophy 12/2023 - 01/2019
4	Muscle Weakness 01/2022 - 01/2015
4	Neoplasms (Cancer) 01/2022 - 08/2012
4	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2020 - 01/2005
4	Parkinsonian Disorders (Parkinsonism) 01/2019 - 02/2006
4	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 07/2012 - 02/2009
3	Seizures (Absence Seizure) 10/2023 - 01/2008
3	Amyloidosis 04/2023 - 01/2012
3	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 03/2011
3	Polymyositis 01/2022 - 01/2019
3	Drug-Related Side Effects and Adverse Reactions 01/2022 - 10/2019
3	COVID-19 10/2021 - 05/2020
3	Atrophy 02/2018 - 08/2005
3	Heart Failure 10/2017 - 05/2013
3	Eye Abnormalities (Eye Abnormality) 10/2010 - 07/2003
2	Status Epilepticus (Complex Partial Status Epilepticus) 04/2024 - 01/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2024 - 01/2013
2	Ischemic Stroke 12/2023 - 10/2014
2	Gaucher Disease (Gaucher's Disease) 08/2023 - 04/2015
2	Ataxia (Dyssynergia) 05/2023 - 01/2015
2	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2023 - 01/2020
2	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 01/2020
2	Neuromuscular Diseases (Neuromuscular Disease) 10/2022 - 01/2020
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 08/2022 - 03/2003
2	Chronic Kidney Failure (Chronic Renal Failure) 07/2022 - 09/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2022 - 01/2021
2	Thymoma (Thymic Carcinoma) 05/2022 - 01/2019
2	Inclusion Body Myositis 01/2022 - 01/2020
2	Multiple Sclerosis 01/2022 - 01/2015
2	Takotsubo Cardiomyopathy 01/2022 - 01/2022
2	Fibrosis (Cirrhosis) 01/2021 - 11/2019
2	Psychotic Disorders (Schizoaffective Disorder) 05/2020 - 08/2006
2	X-Linked Bulbo-Spinal Atrophy 01/2020 - 04/2007
2	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2020 - 01/2018
2	Cognitive Dysfunction 01/2019 - 01/2019
2	Melanoma (Melanoma, Malignant) 11/2018 - 08/2012
2	Malformations of Cortical Development 01/2018 - 06/2005
2	Atrial Fibrillation 10/2017 - 05/2013

Drug/Important Bio-Agent (IBA)

33	Dystroglycans (Dystroglycan)IBA 01/2023 - 03/2002
27	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2003
17	polyglutamineIBA 01/2020 - 06/2003
10	protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA 01/2016 - 03/2002
8	Laminin (Merosin)IBA 08/2022 - 06/2003
7	AntibodiesIBA 01/2023 - 05/2013
7	LigandsIBA 10/2016 - 07/2003
6	Amyloid (Amyloid Fibrils)IBA 12/2023 - 08/2007
6	EnzymesIBA 11/2023 - 01/2006
6	AutoantibodiesIBA 01/2022 - 03/2011
6	RibitolIBA 01/2022 - 03/2016
6	Polysaccharides (Glycans)IBA 01/2020 - 08/2012
6	GlycosyltransferasesIBA 01/2016 - 04/2006
5	alpha-SynucleinIBA 01/2022 - 02/2006
5	Phosphates (Orthophosphate)IBA 01/2022 - 03/2016
4	SynucleinsIBA 12/2023 - 11/2013
4	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 05/2013
4	Peptides (Polypeptides)IBA 01/2020 - 01/2005
4	NucleotidesIBA 03/2015 - 08/2005
3	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
3	Levodopa (L Dopa)FDA LinkGeneric 11/2023 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
3	Cholinergic ReceptorsIBA 05/2022 - 04/2006
3	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 03/2017
3	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
3	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2014
3	Complementary DNA (cDNA)IBA 11/2007 - 03/2003
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 01/2019
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2021
2	SpectrinIBA 08/2022 - 08/2005
2	SteroidsIBA 08/2022 - 03/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 07/2022 - 01/2020
2	Zonisamide (Zonegran)FDA LinkGeneric 01/2022 - 08/2020
2	CholesterolIBA 01/2022 - 01/2022
2	Arginine (L-Arginine)FDA Link 01/2022 - 01/2020
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2022 - 01/2022
2	Acetazolamide (Diamox)FDA LinkGeneric 01/2021 - 09/2014
2	Mitochondrial DNA (mtDNA)IBA 01/2021 - 01/2015
2	SodiumIBA 05/2020 - 09/2018
2	GadoliniumIBA 01/2020 - 11/2019
2	TransferasesIBA 01/2020 - 01/2018
2	Indicators and Reagents (Reagents)IBA 03/2018 - 07/2003
2	Retinaldehyde (Retinal)IBA 02/2018 - 08/2008
2	DystrophinIBA 04/2016 - 01/2006
2	Mannose (D-Mannose)IBA 01/2016 - 10/2010

Therapy/Procedure

11	Therapeutics 12/2023 - 01/2012
2	Hematopoietic Stem Cell Transplantation 02/2024 - 08/2023